Zachary M. Nash

1.1k total citations
9 papers, 654 citations indexed

About

Zachary M. Nash is a scholar working on Microbiology, Molecular Biology and Endocrinology. According to data from OpenAlex, Zachary M. Nash has authored 9 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Microbiology, 4 papers in Molecular Biology and 4 papers in Endocrinology. Recurrent topics in Zachary M. Nash's work include Bacterial Infections and Vaccines (5 papers), Escherichia coli research studies (4 papers) and Bacterial Genetics and Biotechnology (3 papers). Zachary M. Nash is often cited by papers focused on Bacterial Infections and Vaccines (5 papers), Escherichia coli research studies (4 papers) and Bacterial Genetics and Biotechnology (3 papers). Zachary M. Nash collaborates with scholars based in United States, Switzerland and Israel. Zachary M. Nash's co-authors include Isaac F. López-Moyado, Nicholas Stroustrup, Javier Apfeld, Walter Fontana, Leif W. Ellisen, Douangsone D. Vadysirisack, M. Phillip DeYoung, Peter Horak, Dennis C. Sgroi and Peggy A. Cotter and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Zachary M. Nash

9 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zachary M. Nash United States 7 278 223 149 103 89 9 654
Dara P. Dowlatshahi United States 5 383 1.4× 413 1.9× 235 1.6× 79 0.8× 33 0.4× 7 839
Mihwa Seo South Korea 10 363 1.3× 296 1.3× 98 0.7× 30 0.3× 117 1.3× 11 624
Xiaoyan Yin China 16 479 1.7× 338 1.5× 125 0.8× 27 0.3× 68 0.8× 46 989
György Csikós Hungary 11 310 1.1× 188 0.8× 98 0.7× 323 3.1× 35 0.4× 16 683
Christopher R. Burtner United States 13 861 3.1× 461 2.1× 272 1.8× 88 0.9× 22 0.2× 16 1.2k
Shi‐Ming Luo China 16 506 1.8× 35 0.2× 68 0.5× 93 0.9× 39 0.4× 50 973
Michael Frochaux Switzerland 8 279 1.0× 40 0.2× 65 0.4× 45 0.4× 29 0.3× 10 488
Jay E. Johnson United States 18 581 2.1× 131 0.6× 218 1.5× 52 0.5× 30 0.3× 28 1.1k
Lisa Sharling United States 10 431 1.6× 63 0.3× 124 0.8× 182 1.8× 22 0.2× 17 843
Serena Abbondante United States 11 189 0.7× 29 0.1× 133 0.9× 48 0.5× 35 0.4× 17 486

Countries citing papers authored by Zachary M. Nash

Since Specialization
Citations

This map shows the geographic impact of Zachary M. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zachary M. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zachary M. Nash more than expected).

Fields of papers citing papers by Zachary M. Nash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zachary M. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zachary M. Nash. The network helps show where Zachary M. Nash may publish in the future.

Co-authorship network of co-authors of Zachary M. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Zachary M. Nash. A scholar is included among the top collaborators of Zachary M. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zachary M. Nash. Zachary M. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nash, Zachary M., Carol Inatsuka, Peggy A. Cotter, & Richard Johnson. (2024). Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells. mBio. 15(5). e0063224–e0063224. 3 indexed citations
2.
Johnson, Richard, et al.. (2024). Cytochrome oxidase requirements in Bordetella reveal insights into evolution towards life in the mammalian respiratory tract. PLoS Pathogens. 20(7). e1012084–e1012084. 2 indexed citations
3.
Johnson, Richard, et al.. (2021). DegP Initiates Regulated Processing of Filamentous Hemagglutinin in Bordetella bronchiseptica. mBio. 12(3). e0146521–e0146521. 9 indexed citations
4.
Nash, Zachary M. & Peggy A. Cotter. (2019). Regulated, sequential processing by multiple proteases is required for proper maturation and release of Bordetella filamentous hemagglutinin. Molecular Microbiology. 112(3). 820–836. 15 indexed citations
5.
Nash, Zachary M. & Peggy A. Cotter. (2019). BordetellaFilamentous Hemagglutinin, a Model for the Two-Partner Secretion Pathway. Microbiology Spectrum. 7(2). 16 indexed citations
6.
Stroustrup, Nicholas, Winston Anthony, Zachary M. Nash, et al.. (2016). The temporal scaling of Caenorhabditis elegans ageing. Nature. 530(7588). 103–107. 125 indexed citations
7.
Qiao, Shuxi, Michael J. Dennis, Xiufeng Song, et al.. (2015). A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity. Nature Communications. 6(1). 7014–7014. 157 indexed citations
8.
Stroustrup, Nicholas, et al.. (2013). The Caenorhabditis elegans Lifespan Machine. Nature Methods. 10(7). 665–670. 160 indexed citations
9.
Horak, Peter, Douangsone D. Vadysirisack, Zachary M. Nash, et al.. (2010). Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proceedings of the National Academy of Sciences. 107(10). 4675–4680. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026